Multiple Sclerosis Resource Centre

Welcome to the Multiple Sclerosis Resource Centre. This website is intended for international healthcare professionals with an interest in Multiple Sclerosis. By clicking the link below you are declaring and confirming that you are a healthcare professional

Welcome to the Multiple Sclerosis Resource Centre

This Resource Centre provides you with free access to the latest peer-reviewed clinical information relating to the treatment of Multiple Sclerosis. It aims to increase clinical knowledge in the field by disseminating important new research and clinical developments more broadly. It is published in collaboration with the journal Multiple Sclerosis and Related Disorders. All content on this platform is independently selected and reviewed by the Resource Centre’s editors, Professor Tim Vartanian from Cornell University and Dr. Claire S. Riley from Columbia University, both located in New York.

Read more

Articles


About the Editors

  • Prof Timothy Vartanian

    Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
  • Dr Claire S. Riley

    Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...

Upcoming congresses

Search this site

Search form

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe »

This online Resource Centre has been made possible by a donation from EMD Serono, Inc, a subsidiary of Merck KGaA, Darmstadt, Germany and from Pfizer Inc.

Note that EMD Serono, Inc. and Pfizer Inc have had no editorial control or influence over the content of this Resource Centre. The Resource Centre and all content therein have been subject to an independent editorial review

The Grant for Multiple Sclerosis Innovation
supports promising translational research projects by academic researchers to improve understanding of multiple sclerosis (MS) for the ultimate benefit of patients.  For full information and application details, please click here

Journal Editor's choice

Recommended by Prof. Fred Lublin

Smoke and mirrors: Limited value of relative risk reductions for assessing the benefits of disease-modifying therapies for multiple sclerosis

Magda Zakarian
Multiple Sclerosis and Related Disorders; Volume 4, Issue 3